Showing results (101-110 of 184) with videos related to
Sort By:
Pageof 19
Journal of Caffeine Research|January 13, 2017
Concurrent Validity of Caffeine Problems and Diagnostic Criteria for Substance Use DisordersElizabeth Harstad, Georgios Sideridis, Lon Sherritt, et al.The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|May 10, 2024
Identifying Adolescent Vaping With Screening to Brief Intervention and Brief Screener for Tobacco, Alcohol, and Drugs Screening ToolsJennifer A Ross, Machiko Minegishi, Melissa Brogna, et al.Journal of Drugs in Dermatology : JDD|February 2, 2011
Complete clearance is sustained for at least 12 months after treatment of actinic keratoses of the face or balding scalp via daily dosing with imiquimod 3.75% or 2.5% creamC William Hanke, Neil Swanson, Suzanne Bruce, et al.Journal of the American Academy of Dermatology|February 6, 2010
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cyclesNeil Swanson, William Abramovits, Brian Berman, et al.Diseases of the Colon and Rectum|June 3, 2006
Long-term results of "chemical sphincterotomy" for chronic anal fissure: a prospective studyJoseph Lysy, Eran Israeli, Sharon Levy, et al.Journal of Telemedicine and Telecare|September 10, 2002
Future patient care: tele-empowermentSharon Levy, David A Bradley, Moya J Morison, et al.Substance Use & Addiction Journal|December 4, 2024
Screening for Nonmedical Use and Misuse of Prescription Medication by AdolescentsSharon Levy, Machiko Minegishi, Melissa Brogna, et al.AJPM Focus|December 13, 2023
Returning Genetic Information About Risk for Alcohol Use Disorder to Adolescents: Findings of a Preliminary Qualitative Study of Precision PreventionElissa R Weitzman, Laura M Blakemore, Sydney E Pierce, et al.Archives of Dermatological Research|March 6, 2010
Pharmacokinetics of imiquimod 3.75% cream applied daily for 3 weeks to actinic keratoses on the face and/or balding scalpJames Kulp, Sharon Levy, Melanie C Fein, et al.Journal of the American Academy of Dermatology|February 6, 2010
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cyclesC William Hanke, Kenneth R Beer, Eggert Stockfleth, et al.Pageof 19